These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8636965)
1. Protective activity of a murine monoclonal antibody against acute and chronic experimental infection with type IV group B streptococcus. Ricci ML; von Hunolstein C; Gomez MJ; Parisi L; Tissi L; Orefici G J Med Microbiol; 1996 Jun; 44(6):475-81. PubMed ID: 8636965 [TBL] [Abstract][Full Text] [Related]
2. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci. Teti G; Calapai M; Calogero G; Tomasello F; Mancuso G; Galli A; Riggio G Hybridoma; 1992 Feb; 11(1):13-22. PubMed ID: 1371105 [TBL] [Abstract][Full Text] [Related]
3. Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide. VON Hunolstein C; Parisi L; Tissi L; Recchia S; Alfarone G; Nicolini L; Volpe C; Wagner B; Motlova J; Orefici G J Med Microbiol; 1999 Nov; 48(11):983-990. PubMed ID: 10535641 [TBL] [Abstract][Full Text] [Related]
4. Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen. Pincus SH; Smith MJ; Jennings HJ; Burritt JB; Glee PM J Immunol; 1998 Jan; 160(1):293-8. PubMed ID: 9551983 [TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus. Shigeoka AO; Pincus SH; Rote NS; Hill HR J Infect Dis; 1984 Mar; 149(3):363-72. PubMed ID: 6371154 [TBL] [Abstract][Full Text] [Related]
6. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci). von Hunolstein C; D'Ascenzi S; Wagner B; JelĂnková J; Alfarone G; Recchia S; Wagner M; Orefici G Infect Immun; 1993 Apr; 61(4):1272-80. PubMed ID: 8454331 [TBL] [Abstract][Full Text] [Related]
7. The detection of streptococcal antigens using monoclonal antibodies. Harris MC; Polin RA Clin Lab Med; 1985 Sep; 5(3):545-60. PubMed ID: 3899481 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII. Paoletti LC; Pinel J; Johnson KD; Reinap B; Ross RA; Kasper DL J Infect Dis; 1999 Sep; 180(3):892-5. PubMed ID: 10438388 [TBL] [Abstract][Full Text] [Related]
9. Production and partial characterization of monoclonal antibodies to Pasteurella haemolytica A1 capsular polysaccharide and lipopolysaccharide. Penaredondo MV; Maheswaran SK; Whiteley LO; Ames TR; Leininger JR Am J Vet Res; 1988 Nov; 49(11):1962-8. PubMed ID: 2470277 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies in the therapy of experimental neonatal group B streptococcal disease. Hill HR; Kelsey DK; Gonzales LA; Raff HV Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S87-91. PubMed ID: 1728992 [TBL] [Abstract][Full Text] [Related]
11. Conjugate vaccines against group B Streptococcus types IV and VII. Paoletti LC; Kasper DL J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673 [TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of IgM monoclonal antibodies in experimental group B streptococcal infection is a function of antibody avidity. Pincus SH; Shigeoka AO; Moe AA; Ewing LP; Hill HR J Immunol; 1988 Apr; 140(8):2779-85. PubMed ID: 2451694 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody to streptococcal group B carbohydrate: applications in latex agglutination and immunoprecipitin assays. Ruch FE; Smith L J Clin Microbiol; 1982 Jul; 16(1):145-52. PubMed ID: 6809789 [TBL] [Abstract][Full Text] [Related]
14. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin. Bohnsack JF; Hawley MM; Pritchard DG; Egan ML; Shigeoka AO; Yang KD; Hill HR J Immunol; 1989 Nov; 143(10):3338-42. PubMed ID: 2681414 [TBL] [Abstract][Full Text] [Related]
15. Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. Bellais S; Six A; Fouet A; Longo M; Dmytruk N; Glaser P; Trieu-Cuot P; Poyart C J Infect Dis; 2012 Dec; 206(11):1745-52. PubMed ID: 23002446 [TBL] [Abstract][Full Text] [Related]
16. Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes. Raff HV; Siscoe PJ; Wolff EA; Maloney G; Shuford W J Exp Med; 1988 Sep; 168(3):905-17. PubMed ID: 3049909 [TBL] [Abstract][Full Text] [Related]
17. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae. Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies targeting different cell wall antigens of group B streptococcus mediate protection in both Fc-dependent and independent manner. Senn BM; Visram Z; Meinke AL; Neubauer C; Gelbmann D; Sinzinger J; Hanner M; Lundberg U; Boisvert H; Reinscheid D; von Gabain A; Nagy E Vaccine; 2011 May; 29(24):4116-24. PubMed ID: 21496467 [TBL] [Abstract][Full Text] [Related]
19. Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis. Tissi L; Marconi P; Mosci P; Merletti L; Cornacchione P; Rosati E; Recchia S; von Hunolstein C; Orefici G Infect Immun; 1990 Sep; 58(9):3093-100. PubMed ID: 2201646 [TBL] [Abstract][Full Text] [Related]
20. Specificity of monoclonal antibodies against group B streptococcus type II and inhibition of their binding by human secretions. Gray BM; Egan ML; Pritchard DG Pediatr Res; 1988 Jul; 24(1):68-72. PubMed ID: 2457865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]